These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 3891947)
41. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome. Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519 [TBL] [Abstract][Full Text] [Related]
42. Disorders of childhood growth and development: precocious puberty. Chauhan A; Grissom M FP Essent; 2013 Jul; 410():25-31. PubMed ID: 23869392 [TBL] [Abstract][Full Text] [Related]
43. Treatment of central precocious puberty with an LHRH agonist (Buserelin): effect on growth and bone maturation after three years of treatment. Rappaport R; Fontoura M; Brauner R Horm Res; 1987; 28(2-4):149-54. PubMed ID: 2969858 [TBL] [Abstract][Full Text] [Related]
44. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. Laue L; Jones J; Barnes KM; Cutler GB J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081 [TBL] [Abstract][Full Text] [Related]
45. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060 [TBL] [Abstract][Full Text] [Related]
46. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty. Lin TH; LePage ME; Henzl M; Kirkland JL J Pediatr; 1986 Dec; 109(6):954-8. PubMed ID: 2946840 [TBL] [Abstract][Full Text] [Related]
47. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue. Dacou-Voutetakis C; Karidis N Ann N Y Acad Sci; 1993 May; 687():250-4. PubMed ID: 8323180 [TBL] [Abstract][Full Text] [Related]
48. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty. Belgorosky A; Rivarola MA Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807 [TBL] [Abstract][Full Text] [Related]
49. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty. Swaenepoel C; Chaussain JL; Roger M Horm Res; 1991; 36(3-4):126-30. PubMed ID: 1840142 [TBL] [Abstract][Full Text] [Related]
50. [The relation between the secretion of growth hormone (GH), somatomedin C/IGF I (IGF I) and steroids before and after the onset of puberty in patients of small stature]. Garnier P; Nahoul K; Grenier J; Raynaud F; Job JC Ann Pediatr (Paris); 1990 May; 37(5):315-22. PubMed ID: 2142388 [TBL] [Abstract][Full Text] [Related]
51. [Relation of the secretion of growth hormone (GH), somatomedin C/IGF I (IGF I) and steroids before and after the beginning of puberty in patients of short stature]. Garnier P; Nahoul K; Grenier J; Raynaud F; Job JC Pathol Biol (Paris); 1990 Feb; 38(2):105-12. PubMed ID: 2138277 [TBL] [Abstract][Full Text] [Related]
52. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. Feuillan PP; Jones J; Cutler GB J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686 [TBL] [Abstract][Full Text] [Related]
53. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. Cara JF; Kreiter ML; Rosenfield RL J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661 [TBL] [Abstract][Full Text] [Related]
54. Intranasal LH-RH analogue treatment of precocious puberty. Koehler B; Koehler M; Osuch-Jaczewska R Exp Clin Endocrinol; 1988 Mar; 92(3):252-6. PubMed ID: 3075552 [TBL] [Abstract][Full Text] [Related]
55. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). Carel JC; Lahlou N; Jaramillo O; Montauban V; Teinturier C; Colle M; Lucas C; Chaussain JL J Clin Endocrinol Metab; 2002 Sep; 87(9):4111-6. PubMed ID: 12213857 [TBL] [Abstract][Full Text] [Related]
56. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Cara JF; Rosenfield RL; Furlanetto RW Am J Dis Child; 1987 May; 141(5):562-4. PubMed ID: 3578171 [TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty. Kanety H; Karasik A; Pariente C; Kauschansky A Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132 [TBL] [Abstract][Full Text] [Related]
58. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)]. Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732 [No Abstract] [Full Text] [Related]
59. Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue. Oliveira SB; Donnadieu M; Chaussain JL Horm Res; 1993; 39(1-2):42-6. PubMed ID: 8406338 [TBL] [Abstract][Full Text] [Related]
60. Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty. Angeli A; Boccuzzi G; Bisbocci D; Fonzo D; Frajria R; DeSanctis C; Ceresa F J Clin Endocrinol Metab; 1976 Mar; 42(3):551-60. PubMed ID: 767354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]